Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Net Margin (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Net Margin data on record, last reported at 26.81% in Q3 2025.

  • For Q3 2025, Net Margin fell 880.0% year-over-year to 26.81%; the TTM value through Sep 2025 reached 64.22%, up 5636.0%, while the annual FY2024 figure was 33.92%, 203.0% up from the prior year.
  • Net Margin reached 26.81% in Q3 2025 per UTMD's latest filing, down from 30.62% in the prior quarter.
  • Across five years, Net Margin topped out at 175.69% in Q4 2024 and bottomed at 60.85% in Q4 2023.
  • Average Net Margin over 5 years is 29.43%, with a median of 31.47% recorded in 2023.
  • Peak YoY movement for Net Margin: tumbled -9034bps in 2022, then surged 23655bps in 2024.
  • A 5-year view of Net Margin shows it stood at 32.0% in 2021, then tumbled by -282bps to 58.34% in 2022, then dropped by -4bps to 60.85% in 2023, then surged by 389bps to 175.69% in 2024, then tumbled by -85bps to 26.81% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 26.81% in Q3 2025, 30.62% in Q2 2025, and 31.32% in Q1 2025.